Analysts Offer Insights on NA Companies: FedEx (FDX), Sunbelt Rentals Holdings Inc (SUNB) and Telix Pharmaceuticals Limited Unsponsored ADR (TLX)

Analysts from Wells Fargo and H.C. Wainwright maintained Buy ratings on FedEx (FDX) with a $425 target, Sunbelt Rentals (SUNB) with a $104 target, and Telix Pharmaceuticals (TLX) with a $20 target, citing bullish sentiments.

Original reporting
Published Oct 1, 2026, 10:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 11:06 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts Offer Insights on NA Companies: FedEx (FDX), Sunbelt Rentals Holdings Inc (SUNB) and Telix Pharmaceuticals Limited Unsponsored ADR (TLX) — source image
Decision brief

The 30-second read

$FDXBullishMed
01

Why it matters

Analyst upgrades can act as catalysts, especially when targets imply large upside, prompting short-term buying.

02

Market read

Three separate buy ratings with elevated price targets may generate buying interest across logistics, equipment rental, and biotech ADR sectors.

03

What to watch

Potential supply-chain constraints or regulatory risks for Telix are not addressed.

Relevance 5/10Novelty 5/10Timing: today

Background

The article aggregates recent analyst upgrades and price targets for three North American companies.

Company-level read

Ticker impact

$FDXBullishHigh confidence
Context

Wells Fargo analyst upgraded FedEx to Buy with a $425 price target, higher than current price.

Expected impact

potential upward pressure as investors price in the higher target.

Evidence & confidence

Buy rating and $425 target represent a ~48% upside from the last close, likely to attract buying.

$SUNBBullishHigh confidence
Context

Wells Fargo analyst reiterated Buy on Sunbelt Rentals with a $104 price target, above current levels.

Expected impact

likely modest buying pressure toward the $104 target.

Evidence & confidence

Target implies ~41% upside, prompting interest from growth-oriented investors.

$TLXBullishHigh confidence
Context

H.C. Wainwright analyst reiterated Buy on Telix with a $20 price target, well above the last close.

Expected impact

expected upward pressure as market digests the 71% upside implied.

Evidence & confidence

Target suggests significant upside, likely to generate buying interest.

Market effects

Positive analyst sentiment may lift the broader industrial and healthcare ADR segments.

North American equities could see modest gains from the upgrades.

Limited to investors tracking US-listed logistics, equipment rental, and biotech ADRs.

Counterpoint

Some investors may view the upgrades as overly optimistic given broader market volatility.

Key entities

  • Christian Wetherbee

    Wells Fargo analyst covering FedEx.

  • Jerry Revich

    Wells Fargo analyst covering Sunbelt Rentals.

  • Robert Burns

    H.C. Wainwright analyst covering Telix.

Related articles

$FDXMed

Why Is FedEx (FDX) Bringing In Jamere Jackson As CFO?

FedEx (FDX) appointed Jamere Jackson as its new CFO, effective immediately. Jackson has prior CFO experience at large publicly traded companies. He will oversee global finance, including treasury, tax, and investor relations. FedEx's market cap is $72.2 billion, and the CFO's decisions may impact growth, efficiency, and balance sheet resilience. Investors will watch for cost savings, free cash flow targets, and AI project updates in future earnings reports.

$UNPMed

How These 4 Transportation Stocks Move the Economy

Four transportation stocks—Union Pacific (UNP), CSX (CSX), UPS (UPS), and FedEx (FDX)—have outperformed the Nasdaq Transportation index in 2026. UNP reported Q3 revenue of $7.2B (+15% YoY) and net income of $2.1B (+16% YoY). CSX saw record Q3 revenue of $4.02B (+12% YoY) and EPS growth of 54%. UPS's Q3 revenue rose 6.7% to $22.9B, while FedEx's adjusted EPS increased 28% to $3.74. All companies are navigating higher fuel costs and shifting demand.

$TLXMed

Telix Pharmaceuticals Targets $1.5B Revenue as ITM Deal Speeds Therapy Push

Telix Pharmaceuticals (NASDAQ:TLX) aims for $1.5B in revenue next year, driven by its prostate cancer imaging and therapy programs. Key studies include BiPASS for PSMA-PET imaging and OPTIMAL-PSMA for TLX597-Tx therapy. The company also advances programs for brain and kidney cancer, with FDA approvals expected for PIXCLARA and a decision pending for Zircaix. Telix expects six approved products by next year, subject to regulatory approvals.

$FDXHighAI 8/10

FedEx Network 2.0 headed to Los Angeles, other markets post-holidays

FedEx has completed its Network 2.0 overhaul in several U.S. markets, with 65% of eligible volume now flowing through optimized stations. The company plans to expand the initiative to Los Angeles and other markets post-holidays, aiming for $2 billion in cost savings by 2024. FedEx also reported higher costs due to labor and fuel prices, but expects 12% full-year revenue growth.

$FDXHighAI 8/10

FedEx CEO is seeing a shift in its customer base

FedEx reported Q3 revenue of $22.9B (+12%) and adjusted EPS of $3.74 (+28%), driven by a shift to higher-margin customers. The company is focusing on business-to-business, healthcare, and data center logistics, with international operations showing strong growth. FedEx plans to close 475 locations by 2027, aiming for $2B in savings. Full-year adjusted EPS guidance was raised to $18.00-$18.60.